This inventor holds 34 USPTO granted patents and 8 published patent applications and 4 EPO patents, primarily in Ocular Delivery Systems. Top assignees: Sight Sciences, Inc., Boston Scientific Scimed, Inc.. Active years: 2014-2026.
Company Filing History:
32 out of 62 
1 out of 6,594 
Years Active: 2014-2026
Areas of Expertise:
Title: Innovator Spotlight: Daniel O'Keeffe and His Contributions to Ocular Delivery Systems
Introduction: Daniel O'Keeffe is a prominent inventor based in San Francisco, CA, with an impressive portfolio comprising 27 patents. His groundbreaking work primarily focuses on ocular delivery systems and innovative methods to treat eye conditions, particularly those related to elevated intraocular pressure.
Latest Patents: Among Daniel's notable inventions are systems and methods aimed at accessing Schlemm's canal for the delivery of ocular devices, tools, or fluid compositions. His patents detail the use of viscoelastic fluids that facilitate drainage of aqueous humor by disrupting both Schlemm's canal and surrounding trabeculocanalicular tissues. These innovative tools are designed to maintain the patency of the canal while minimally interfering with fluid flow, making them essential in the treatment of conditions such as glaucoma.
Career Highlights: Daniel has made significant contributions to the field of medical technologies while working with reputable companies such as Sight Sciences, Inc. and Boston Scientific Scimed, Inc. His expertise in developing novel ocular therapies has notably influenced practices in ophthalmology, enhancing patient outcomes in eye care.
Collaborations: Throughout his career, Daniel has collaborated with noteworthy professionals, including David Y Badawi and Paul Badawi. Their collective efforts have advanced research and innovations in the development of ocular delivery systems, reflecting a strong team approach in tackling complex medical challenges.
Conclusion: Daniel O'Keeffe stands out as a key figure in ocular innovation, with a rich history of patents and collaborations. His dedication to improving eye health through innovative delivery systems showcases the potential for advancements in medical technology and provides hope for effective treatments for conditions like glaucoma. The impact of his work continues to influence the field, driving forward the possibilities in ocular health solutions.